Variation in the estimated costs of pivotal clinical benefit trials supporting the US approval of new therapeutic agents, 2015–2017: a cross-sectional studyThomas J Moore, James Heyward, Gerard Anderson, G Caleb Alexander
11 June 2020
Chinese physicians’ attitudes toward eco-directed sustainable prescribing from the perspective of ecopharmacovigilance: a cross-sectional studyJun Wang, Shulan Li, Bingshu He
1 June 2020
Cannabidiol (CBD) and Δ-tetrahydrocannabinol (THC) for chronic insomnia disorder (‘CANSLEEP’ trial): protocol for a randomised, placebo-controlled, double-blinded, proof-of-concept trialAnastasia Suraev, Ronald R Grunstein, Nathaniel S Marshall, Angela L D'Rozario, Christopher J Gordon, Delwyn J Bartlett, Keith Wong, Brendon J Yee, Ryan Vandrey, Chris Irwin, Jonathon C Arnold, Iain S McGregor, Camilla M Hoyos
18 May 2020
Are monitoring instructions provided in direct healthcare professional communications (DHPCs) of sufficient quality? A retrospective analysis of DHPCs sent out between 2007 and 2018Maja-Marie Grønfeldt Højer, Marie Louise De Bruin, Arnela Boskovic, Christine Erikstrup Hallgreen
11 May 2020
Severity of coeliac disease and clinical management study when using a CYP3A4 metabolised medication: a phase I pharmacokinetic studyMarc L Chretien, David G Bailey, Linda Asher, Jeremy Parfitt, David Driman, Jamie Gregor, George K Dresser
4 March 2020
Healthcare professionals knowledge, attitude and practice of adverse drug reactions reporting in Ethiopia: a cross-sectional studyKidu Gidey, Mohammedamin Seifu, Berhane Yohannes Hailu, Solomon Weldegebreal Asgedom, Yirga Legesse Niriayo
25 February 2020
Zinc acetate lozenges for the treatment of the common cold: a randomised controlled trialHarri Hemilä, Jari Haukka, Marianne Alho, Jussi Vahtera, Mika Kivimäki
23 January 2020
Lithium for Fracture Treatment (LiFT): a double-blind randomised control trial protocolDiane Nam, Phumeena Balasuberamaniam, Katrine Milner, Monica Kunz, Kathak Vachhani, Alex Kiss, Cari Whyne
7 January 2020
Cannabinoids versus placebo or no intervention for pain: protocol for a systematic review with meta-analysis and trial sequential analysisJehad Ahmad Barakji, Steven Kwasi Korang, Joshua Feinberg, Mathias Maagard, Christian Gluud, Ole Mathiesen, Janus Christian Jakobsen
31 October 2019
Use of real-world evidence in postmarketing medicines regulation in the European Union: a systematic assessment of European Medicines Agency referrals 2013–2017Jeremy Philip Brown, Kevin Wing, Stephen J Evans, Krishnan Bhaskaran, Liam Smeeth, Ian J Douglas
28 October 2019
